Mimedx (MDXG) Amortization of Deferred Charges (2011 - 2025)

Mimedx has disclosed Amortization of Deferred Charges across 14 years of filings, most recently posting $135000.0 for Q1 2025.

• Amortization of Deferred Charges for Q1 2025 came in at $135000.0, up 95.65% year-over-year; the trailing twelve-month figure through Mar 2025 was $352000.0 (down 16.19% YoY), and the FY2023 annual result was $505000.0, up 8.14% from the prior year.
• Amortization of Deferred Charges came in at $135000.0 for Q1 2025 at Mimedx, up from $16000.0 in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $415000.0 in Q1 2021 to a low of $16000.0 in Q3 2024.
• The 5-year median for Amortization of Deferred Charges is $111500.0 (2021), against an average of $124714.3.
• Across the five-year window, Amortization of Deferred Charges sank 85.59% in 2024 and soared 95.65% in 2025, its largest moves.
• Mimedx's Amortization of Deferred Charges stood at $112000.0 in 2021, then rose by 6.25% to $119000.0 in 2022, then grew by 10.92% to $132000.0 in 2023, then sank by 87.88% to $16000.0 in 2024, then surged by 743.75% to $135000.0 in 2025.
• The last three Amortization of Deferred Charges figures came in at $135000.0 (Q1 2025), $16000.0 (Q3 2024), and $69000.0 (Q1 2024), per Business Quant data.